São Paulo - Delayed Quote BRL
Eli Lilly and Company (LILY34.SA)
161.31
+4.79
+(3.06%)
As of 2:17:00 PM GMT-3. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 18 | 15 | 28 | 26 |
| Avg. Estimate | 12.72B | 14.35B | 59.52B | 71.64B |
| Low Estimate | 12.39B | 13.86B | 57.95B | 65.07B |
| High Estimate | 13.16B | 14.61B | 62.08B | 79.59B |
| Year Ago Sales | 8.77B | 11.3B | 45.04B | 59.52B |
| Sales Growth (year/est) | 45.09% | 26.92% | 32.14% | 20.36% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LILY34.SA | -- | -- | -- | -- |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Related Tickers
N1VO34.SA Novo Nordisk A/S
44.27
+1.75%
BRM.F Bristol-Myers Squibb Company
42.57
-0.53%
4519.T Chugai Pharmaceutical Co., Ltd.
8,251.00
+0.70%
4568.T Daiichi Sankyo Company, Limited
3,316.00
+0.85%
NOV.F Novo Nordisk A/S
55.29
+1.75%
DSNKY Daiichi Sankyo Company, Limited
23.50
+1.34%
MDCX Medicus Pharma Ltd.
4.0100
+2.04%
NOVO-B.CO Novo Nordisk A/S
410.10
+0.29%
NOVN.SW Novartis AG
92.00
+1.21%
AZN AstraZeneca PLC
69.31
+1.17%